Clinical Trial: Young Plasma Transfusions for Progressive Supranuclear Palsy

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: A 6 Month, Open-Label, Pilot Futility Clinical Trial of Monthly Young Healthy Male Donor Plasma Transfusions for Progressive Supranuclear Palsy

Brief Summary: This is a phase 1, multi-center, open-label study of the safety, tolerability, pharmacodynamics, and preliminary efficacy of young (<30 years of age) healthy male donor plasma transfusions in patients with PSP. Up to 10 subjects will receive once monthly 4-unit transfusions of young healthy male donor plasma for 6 months.